Metagenics Releases Hemp Advantage™ Plus

ALISO VIEJO, Calif., Oct. 17, 2019 /PRNewswire/ — Metagenics, Inc., a health sciences company, announced today the release of Hemp Advantage Plus, the third formula launched this year in the Metagenics hemp line. Hemp Advantage Plus combines an organic, broad-spectrum hemp extract with palmitoylethanolamide (PEA) in a patent-pending formula.

PEA is a naturally occurring compound found in lipid extracts of foods and plants, as well as in the body’s organs and fluids. It has been clinically studied on more than 4,000 people worldwide for its safety and efficacy, and numerous studies have shown that PEA supports bodily comfort and increases subjective measures of quality of life.*

The phytocannabinoids and terpenes in hemp along with PEA may work synergistically to support endocannabinoid system (ECS) function and modulate balance in the body — providing greater benefits than any of these compounds alone, also known as the entourage effect.*

“The endocannabinoid system is a rapidly growing area of interest for practitioners, patients, and researchers alike,” shares Matthew Martinez, Metagenics General Manager of North America. “By combining hemp with PEA, we’re leveraging science on the endocannabinoid system and the entourage effect to offer an innovative, practitioner-exclusive formula.”

Metagenics continues with its focus on transparency by including Hemp Advantage Plus in its TruQuality® program, an initiative that provides practitioners and patients full access to analytical data from quality assurance tests performed on each lot of Metagenics products. Hemp Advantage Plus is glyphosate-tested; other tests are done for heavy metals, pesticides, solvent residues, environmental contaminants, and common allergens, including gluten.

For more information on Metagenics hemp formulas, visit Metagenics.com/hemp.

About Metagenics, Inc.
Metagenics was founded on a revolutionary idea: Our genes do not predetermine our health potential, and through nutrition, we can impact how our genes express themselves. Embodied by our company motto — genetic potential through nutrition — this groundbreaking principle drives us to deliver high-quality, science-based nutritional supplements, medical foods, and lifestyle programs to support healthcare practitioners in their efforts to help patients achieve their health goals. With a range of nutritional solutions designed to support individual lifestyles, including non-GMO, gluten-free, and vegetarian offerings, we remain committed to supplying practitioners around the world with advanced tools to help support patient care.

 *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Media Contact:
Rocky Morris
Metagenics
949-369-3337

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/metagenics-releases-hemp-advantage-plus-300940215.html

SOURCE Metagenics, Inc.

Staff

Recent Posts

Defence Announces Closing of Securities for Debenture Financing

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…

4 hours ago

NuGen Announces Canada-Wide Launch of InsuJet

3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…

5 hours ago

purelyIV Launches Mobile App for Seamless Wellness Management

The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…

5 hours ago

Independence Blue Cross launches Epic Payer Platform to transform care coordination and boost member health outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform…

5 hours ago